Thirty eight cases with acute leukemia were treated with consolidation therapy immediately after obtaining complete remission and intensification therapy during cyclic maintenance therapy.
The median duration of complete remission for this group was 16 1/3 months and the median survival was 18 2/3 months, whereas 8 and 16 2/3 months for cyclic maintenance therapy only, 4 2/3 and 10 1/3 months for 6MP maintenance therapy and 2 and 8 1/3 months for non-maintenance therapy respectively.
Differences of complete remission length between each of the four groups are statistically significant, whereas that of survival time between consolidation-intensification with cyclic therapy and cyclic therapy only is not significant, but 16 cases in the former group are still alive.
Side effects of consolidation and intensification therapy include nausea, vomiting, epilation, paresthesia and liver function abnormalities. Fever above 38°C was noted during the time of leukopenia after 28 courses of the treatment out of 109.
Eleven cases of hepatitis, 6 cases of pneumonia, one case of exacerbation of pulmonary tuberculosis and 3 cases of herpes zoster were major complications because of which the maintenance therapy had to be interrupted. Almost all of these complications were observed, except for herpes zoster, soon after consolidation treatment that was given following remission induction.
Eight cases (23%) had meningeal infiltration of leukemia during the maintenance therapy prior to hematologic relapse.
It is concluded that intensification and consolidation therapy coupled with cyclic maintenance therapy seem worth-while in prolongation of duration of remission and survival time of patients with acute leukemia.
View full abstract